
-
2005
Company Description
Avexxin's therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases
Avexxin's therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases at the Norwegian University of Science and Technology. Avexxin's goal is to create a therapeutic company based on the discovery and development of novel therapeutics that address the fundamental mechanisms involved in inflammatory diseases.
-
Manufacturer:
Science and Engineering -
Formed:
2005 -
Company Website:
-
Company E-mail:
-
Company Address:
Department of Biology, Norwegian University of Science and Technology, Høgskoleringen 5TrondheimNorway -
CEO:
- Mikael Ørum
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits